The Rutgers Mini-MBA: BioPharma Innovation brings Rutgers thought-leaders and senior industry executives into the classroom in an intensive training program focused on the strategic, regulatory, and management issues confronting the pharmaceutical and biotech sectors. This innovative executive development opportunity provides a comprehensive business foundation for professionals with diverse responsibilities.

Participants will learn about bringing scientific innovation to the marketplace with sustainable success. Session topic areas may include:

• Global context for biopharma
   
• Making strategic business decisions in drug development
   
• Legal and regulatory issues
   
• Innovation in the pharmaceutical/biotech industry
   
• Strategic alliances and acquisitions
   
• Modeling the ROI in R&D
   
• Supply chain development

The Mini MBA covers the entire drug development process – from discovery to commercialization. The program provides the background and business skills required for innovation in these industries, while also challenging participants to consider new business paradigms that promote sustainable revenue growth, stakeholder cooperation and cost management.

For more information about the Mini-MBA: BioPharma Innovation Program, or to find out how to bring this program to your location, call 732-445-5526 or send an e-mail to info@cmd.rutgers.edu.